MAP2K7 and melanoma: Moreover, other previous studies uncovered data on specific interplay between MEK signaling and Ido-1 activation in dendritic cells in tumor microenvironment [7] and on activation of Ido-1 expression by MEK-inhibitors in melanoma patients [8].